Background: In recent years experience has been accumulated in percutaneous radiofrequency ablation (RFA) of lung malignancies in nonsurgical patients. Objectives: In this study, we retrospectively evaluated a simultaneous diagnostic and therapeutic approach including CT-guided biopsy followed immediately by RFA of solitary malignant pulmonary lesions. Methods: CT-guided transthoracic core needle biopsy of solitary pulmonary lesions suspicious for malignancy was performed and histology was proven based on immediate frozen sections. RFA probes were placed into the pulmonary tumors under CT guidance and the ablation was performed subsequently. The procedure-related morbidity was analyzed. Follow-up included a CT scan and pulmonary function parameters. Results: A total of 33 CT-guided biopsies and subsequent RFA within a single procedure were performed. Morbidity of CT-guided biopsy included pulmonary hemorrhage (24%) and a mild pneumothorax (12%) without need for further interventions. The RFA procedure was not aggravated by the previous biopsy. The rate of pneumothorax requiring chest tube following RFA was 21%. Local tumor control was achieved in 77% with a median follow-up of 12 months. The morbidity of the CT-guided biopsy had no statistical impact on the local recurrence rate. Conclusions: The simultaneous diagnostic and therapeutic approach including CT-guided biopsy followed immediately by RFA of solitary malignant pulmonary lesions is a safe procedure. The potential of this combined approach is to avoid unnecessary therapies and to perform adequate therapies based on histology. Taking the local control rate into account, this approach should only be performed in those patients who are unable to undergo or who refuse surgery.
A new surface-based method that approximates the mammographic deformation due to breast compression without using a specific complex model needed for finite-element-based methods was developed and tested with favorable results. The simulated compression can serve as foundation for a point-to-line correspondence between 2D mammograms and 3D MR image data.
Purpose Iodine-containing contrast agent (CA) used in contrast-enhanced CT angiography (CTA) can pose a health risk for patients. A system that adjusts the frequently used standard CA dose for individual patients based on their clinical parameters can be useful. As basis the quality of the image contrast in CTA volumes has to be determined, especially to recognize excessive contrast induced by CA overdosing. However, a manual assessment with a ROI-based image contrast classification is a time-consuming step in everyday clinical practice. Methods We propose a method to automate the contrast measurement of aortic CTA volumes. The proposed algorithm is based on the mean HU values in selected ROIs that were automatically positioned in the CTA volume. First, an automatic localization algorithm determines the CTA image slices for certain ROIs followed by the localization of these ROIs. A rule-based classification using the mean HU values in the ROIs categorizes images with insufficient, optimal and excessive contrast. Results In 95.89% (70 out of 73 CTAs obtained with the ulrich medical CT motion contrast media injector) the algorithm chose the same image contrast class as the radiological expert. The critical case of missing an overdose did not occur with a positive predicative value of 100%. Conclusion The resulting system works well within our range of considered scan protocols detecting enhanced areas in CTA volumes. Our work automized an assessment for classifying CA-induced image contrast which reduces the time needed for medical practitioners to perform such an assessment manually.
Background Detection of breast cancer in women with high breast densities is a clinical challenge. Purpose To study the influence of different degrees of breast density on the sensitivity of contrast-enhanced breast magnetic resonance imaging (CE-BMRI) versus X-ray mammography (XRM). Material and Methods We performed an additional analysis of two large Phase III clinical trials (G1; G2) which included women with histologically proven breast cancers, called “index cancers.” Additional cancers were detected during image reading. We compared the sensitivity of CE-BMRI and XRM in women with different breast densities (ACR A→D; Version 5). For each study, six blinded readers evaluated the images. Results are given as the “Median Reader.” Results A total of 774 patients were included, 169 had additional cancers. While sensitivity of CE-BMRI for detecting all index cancers was independent of breast density (ACR A→D) (G1: 83%→83%; G2: 91%→91%) the sensitivity of XRM declined (ACR A→D) (G1: 79%→62%; G2: 82%→64%). Thus, the sensitivity difference between both imaging modalities in ACR A breasts of 3% (G1) and 9% (G2) increased to 21% (G1) and 26% (G2) in ACR D breasts. Sensitivity of CE-BMRI for detecting at least one additional cancer increased with increasing breast density (ACR A→D) (G1: 50%→73%, G2: 57%→81%). XRM’s sensitivity decreased (G1: 34%→20%) or remained stable (G2: 24%→25%). Conclusion CE-BMRI showed significantly higher sensitivity compared to XRM.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.